April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
May 2016

Webinar : ECG Assessment in Early Phase 1 Studies: How to get it right for possible TQT waiver?

May 19th, 2016 Duration: 1 hour   To know more click on the…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
Mission & strategy > Banook Group at a glance

Banook Group at a glance

 

 

Three business lines

The Banook Group is a leading player in the service market for the generation and management of clinical trial data. Throughout the years we have progressively developed and focused our activities around three main areas: cardiac safety, central imaging and endpoint adjudication.

 

Today, only a handful of clinical trial service providers are able to offer this broad expertise.

Cardiac SafetyCentral ImagingEndpoint Adjudication.

One know-how

Our expertise does not simply consist in collecting and analyzing clinical trial data. Above all, we take pride in being responsive to your needs and helping you meet your objectives.

 

  • We listen attentively to you to meet your specific needs and adjust to your environment,
  • We constantly monitor technological and operational advances to ensure you benefit from state-of-the-art approaches and fulfill your mission of bringing innovative solutions to patients as rapidly as possible.

Global coverage

 

Strong experience on 5 continents including emerging countries

 

Coverage

 

coverage

 

 

 

From single center early phase

to multicenter late phase trials

Repartition / Phase

Broad range of therapeutic areas

  • Oncology,
  • Cardiovascular including antiarrhythmic,
  • Pulmonary/respiratory,
  • Central nervous system,
  • Dermatology,
  • Infectious diseases, malaria, and other tropical disease (HAT, Chagas diseases, Leishmanionis ….),
  • Pediatric including very young infants,
  • Metabolic diseases,
  • Rheumatology.

HIGH QUALITY DATA

Clinical trial data is handled through a unique fully integrated software suite : AtriumTM. Atrium TM is specifically designed to build, operate, track and document Clinical Trials across all study phases from Electronic Data Capture (EDC) to final publications of the meta-data.


Roll up to discover more

Data collection tools

• Multiple sources (Image, ECG, holter…)

• Web upload system

• Secure point-to-point connectivity

• Data extraction & de-identification

Operating system

• Data integration & cleaning

• Automate workflow management

• Data review and export

Analysis tool

• Pos-treatment image tool

• ECG/holter analysis tool

• MACE web adjudication system

Interoperability

• Integrated with PACS, EDC, CTMS systems

Archiving system

• PACS (Picture Archiving Communication System)

• Store data in vendor neutral archive

Communication system

• On-line queries

• Message board

• On-line clinical report

Reporting system

• Operational dashboards

• Key performance indicators

Security and audit

• Compliant with CFR part 11

• Audit-trail

Wide range experience

Since 1999
Companies

125+

Companies (international pharmaceutical, device manufacturers & biotechnology companies) and nonprofit organizations

Patients

60 000+

Patients / Healthy volunteers

Clinical

750+

Clinical trials

(from early to late phases)

ECG

300+

ECGs intense trials

including 20+ TQT clinical trials

ECG

1 000 000+

ECGs

Adjudications

15 000+

Adjudications performed on clinical dossiers

Unique expertise in special populations and conditions
Population

Population:

pediatric co-morbidity

Geographic

Geographic areas:

Africa & other tropical areas (malaria & tropical diseases)

Devices

Medical devices

A stable experienced team

  • SCIENTIFIC ADVISORY BOARD, with international experts,
  • READERS & CONSULTANTS, with international scientific and regulatory expertise
  • EMPLOYEES AT THE SERVICE OF SCIENTIFIC AND OPERATIONAL EXCELLENCE, including:
  • PROJECT & DATA MANAGEMENT STAFF (high level knowledge dedicated to providing accurate, quality clinical trials data),
  • DEVELOPMENT ENGINEERS (designing and validating software to the highest regulatory standards),
  • IN HOUSE QA TEAM (dedicated to clinical trial and quality driven results),
  • DEDICATED LOGISTICAL TEAM (with extensive experience in handling medical devices worlwide).

OPERATIONAL FLEXIBILITY

Quick response and resolution

LOW TURNOVER

≈5%/year
none for management

Key dates

Click and discover more.

1999

Creation of Cardiabase,

a company dedicated to cardiac safety

2004

Starting of endpoint

adjudication activities

2006

Cardiabase becomes the leader in Europe

for early phases studies in cardiac safety

2010

Partnership between Banook

and Institut Gustave Roussy

2011

Creation of Banook Central Imaging,

a company combining the activities of central imaging and endpoint adjudication

2014

Novel approach in imaging biomarkers

(Tumor Growth Rates)

2015

Formation of Banook Group merging

the three areas of expertise:

cardiac safety, central imaging, endpoint adjudication.

A Sound Partnership

Scientific and Regulatory Expertise

Operational Flexibility

IT innovation and combined integrated services

Financial soundness

Contact Us